| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Kangmei Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥1.93 |
| 52 Week High | CN¥2.33 |
| 52 Week Low | CN¥1.68 |
| Beta | 0.56 |
| 11 Month Change | 0.52% |
| 3 Month Change | -3.02% |
| 1 Year Change | -2.53% |
| 33 Year Change | -36.30% |
| 5 Year Change | -36.72% |
| Change since IPO | 43.08% |
Recent News & Updates
We Think Kangmei Pharmaceutical (SHSE:600518) Can Stay On Top Of Its Debt
Jun 17
Kangmei Pharmaceutical's (SHSE:600518) Performance Is Even Better Than Its Earnings Suggest
May 06Kangmei Pharmaceutical Co., Ltd.'s (SHSE:600518) Price Is Out Of Tune With Revenues
Apr 10Shareholder Returns
| 600518 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 4.3% | -3.1% | -0.8% |
| 1Y | -2.5% | -17.3% | -21.8% |
Return vs Industry: 600518 exceeded the CN Pharmaceuticals industry which returned -17.3% over the past year.
Return vs Market: 600518 exceeded the CN Market which returned -21.8% over the past year.
Price Volatility
| 600518 volatility | |
|---|---|
| 600518 Average Weekly Movement | 4.8% |
| Pharmaceuticals Industry Average Movement | 5.0% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in CN Market | 8.9% |
| 10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 600518 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600518's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 4,409 | Guowei Liu | www.kangmei.com.cn |
Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. It also offers chemical medicines and health food; and operates hospitals and pharmacies. Kangmei Pharmaceutical Co., Ltd.
Kangmei Pharmaceutical Co., Ltd. Fundamentals Summary
| 600518 fundamental statistics | |
|---|---|
| Market cap | CN¥26.76b |
| Earnings (TTM) | CN¥160.40m |
| Revenue (TTM) | CN¥4.93b |
166.8x
P/E Ratio5.4x
P/S RatioIs 600518 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600518 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.93b |
| Cost of Revenue | CN¥4.20b |
| Gross Profit | CN¥727.35m |
| Other Expenses | CN¥566.95m |
| Earnings | CN¥160.40m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 24, 2024
| Earnings per share (EPS) | 0.012 |
| Gross Margin | 14.75% |
| Net Profit Margin | 3.25% |
| Debt/Equity Ratio | 0.4% |
How did 600518 perform over the long term?
See historical performance and comparison